Patents by Inventor Thomas Anders Millward

Thomas Anders Millward has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6258776
    Abstract: The invention concerns a method of modulating the activity of a polypeptide comprising the activating domain of an Ndr family kinase, by influencing the binding of an EF hand-containing calcium binding.
    Type: Grant
    Filed: August 12, 1998
    Date of Patent: July 10, 2001
    Assignee: Novartis AG
    Inventors: Brian Arthur Hemmings, Thomas Anders Millward
  • Patent number: 6040164
    Abstract: The current invention describes the identification of a novel widely-expressed human and D. melanogaster serine/threonine protein kinase (designated nuclear, Dbf2-related kinase, or Ndr; previously referred to as Ndr) and the use of this kinase for the identification of agonists and antagonists. The kinase is a nuclear protein and contains a short basic peptide, KRKAETWKRNRR, responsible for the nuclear accumulation.
    Type: Grant
    Filed: June 22, 1999
    Date of Patent: March 21, 2000
    Assignee: Novartis AG
    Inventors: Brian Arthur Hemmings, Thomas Anders Millward
  • Patent number: 5981205
    Abstract: The current invention describes the identification of a novel widely-expressed human and D. melanogaster serine/threonine protein kinase (designated nuclear, Dbf2-related kinase, or Ndr; previously referred to as Ndr) and the use of this kinase for the identification of agonists and antagonists. The kinase is a nuclear protein and contains a short basic peptide, KRKAETWKRNRR, responsible for the nuclear accumulation.
    Type: Grant
    Filed: June 19, 1997
    Date of Patent: November 9, 1999
    Assignee: Novartis AG
    Inventors: Brian Arthur Hemmings, Thomas Anders Millward